Loading...
RCT
Published: Feb 2019
ACE Report #11551
Ace Report Cover Spine

IV and topical TXA superior to placebo for hematological outcomes after PLIF


Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A

Intravenous Administration of Tranexamic Acid Significantly Reduces Visible and Hidden Blood Loss Compared with Its Topical Administration for Double-Segment Posterior Lumbar Interbody Fusion: A Single-Center, Placebo-Controlled, Randomized Trial

World Neurosurg. 2019 Feb;122:e821-e827.

Contributing Authors: J Wei Z Li C Wang X Mu Y Ou D Yin B Liang D Qiu

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.